• Furin Protein Sustains Tumor Signals in KRAS- and BRAF-Mutated Colorectal Cancer

    Preclinical research identifies Furin as a key mediator of the TGF-β1-COX-2 pathway in KRAS- and BRAF-mutant colorectal cancer; blocking Furin suppressed tumor growth and enhanced sensitivity to chemotherapy in organoid models. (Oncogene)